目录:MedChemExpress LLC>>生化试剂>> IRAK4-IN-7 | MCE
CAS | 1801343-74-7 | 纯度 | 99.86% |
---|---|---|---|
分子量 | 417.42 | 分子式 | C₂₁H₁₉N₇O₃ |
供货周期 | 现货 | 规格 | 5 mg |
货号 | HY-109585 | 应用领域 | 医疗卫生,化工,生物产业,制药/生物制药 |
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
CAS No. : 1801343-74-7
产品活性:IRAK4-IN-7 is a selective, potent and orally active interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitor, extracted from patent WO2015104688 (example 1). IRAK4-IN-7 has the potential for cancer and inflammatory diseases treatment.
研究领域:Immunology/Inflammation
作用靶点:IRAK
In Vivo: IRAK4-IN-7 has anti-cancer and anti-inflammatory activities, it can be used for cancer and inflammatory diseases treatment.
相关产品:Drug Repurposing Compound Library Plus | Clinical Compound Library Plus | Bioactive Compound Library Plus | Immunology/Inflammation Compound Library | Kinase Inhibitor Library | Anti-Cancer Compound Library | Clinical Compound Library | Drug Repurposing Compound Library | Orally Active Compound Library | Targeted Diversity Library | Heterocyclic Compound Library | IRAK4-IN-4 | HS-276 | HS-243 | IRAK inhibitor 2 | IRAK4-IN-14 | HG-12-6 | IRAK4-IN-13 | Zabedosertib | KTX-612 | IRAK inhibitor 6 | KTX-582 | IRAK4-IN-19 | AZ1495 | IRAK4-IN-1 | IRAK4-IN-21 | PROTAC IRAK4 degrader-5 | IRAK4-IN-17 | IRAK4-IN-12 | PROTAC IRAK4 degrader-6 | KTX-951 | IRAK4-IN-22 | IRAK4-IN-11 | JH-X-119-01 hydrochloride | PF-06426779 | IRAK4-IN-16 | Ginsenoside Rb1 | KTX-497 | IRAK-1-4 Inhibitor I
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物 | 寡核苷酸 | 抗体 | 点击化学
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides | Antibodies | Click Chemistry
品牌介绍:
• MCE (MedChemExpress) 拥有200 多种*仅有化合物库,我们致力于为*科研客户提供前沿的高品质小分子活性化合物;
• 50,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领;
• 产品种类涵盖各种重组蛋白,多肽,常用试剂盒 ,更有 PROTAC、ADC 等特色产品,广泛应用于新药研发、生命科学等科研项目;
• 提供虚拟筛选,离子通道筛选,代谢组学分析检测分析,药物筛选等专业技术服务;
• 设有专业的实验中心和严格的质控、验证体系;
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告,确保产品的高纯度、高品质;
• 产品的生物活性多经各国客户实验验证;
• Nature, Cell, Science 等多种顶级期刊及制药 Patent 收录了MCE客户的科研成果;
• 专业团队跟踪新的制药及生命科学研究进展,为您提供*新的活性化合物;
• 与世界各大制药公司及*科研机构建立了长期的合作。